The Cladribine Trial in Secondary Progressive Multiple Sclerosis: A Reanalysis.
- Published in:
- Neuroepidemiology, 2000, v. 19, n. 2, p. 109, doi. 10.1159/000026245
- By:
- Publication type:
- Article
Works matching IS 02515350 AND DT 2000 AND VI 19 AND IP 2
Results: 7
1
2
Creutzfeldt-Jakob Disease in a Recipient of a Dura mater Graft Processed in the US: Cause or Coincidence?
- Published in:
- Neuroepidemiology, 2000, v. 19, n. 2, p. 62, doi. 10.1159/000026240
- By:
- Publication type:
- Article
3
Relationship of Family History Scores for Stroke and Hypertension to Quantitative Measures of White-Matter Hyperintensities and Stroke Volume in Elderly Males.
- Published in:
- Neuroepidemiology, 2000, v. 19, n. 2, p. 76, doi. 10.1159/000026242
- By:
- Publication type:
- Article
4
Cost of Illness of Epilepsy in the US: Comparison of Patient-Based and Population-Based Estimates.
- Published in:
- Neuroepidemiology, 2000, v. 19, n. 2, p. 87, doi. 10.1159/000026243
- By:
- Publication type:
- Article
5
How Is Creutzfeldt-Jakob Disease Acquired?
- Published in:
- Neuroepidemiology, 2000, v. 19, n. 2, p. 55, doi. 10.1159/000026239
- By:
- Publication type:
- Article
6
Regional and Temporal Variation in the Incidence of Multiple Sclerosis in Finland 1979-1993.
- Published in:
- Neuroepidemiology, 2000, v. 19, n. 2, p. 67, doi. 10.1159/000026241
- By:
- Publication type:
- Article
7
Patterns of Outcome Measurement in Parkinson's Disease Clinical Trials.
- Published in:
- Neuroepidemiology, 2000, v. 19, n. 2, p. 100, doi. 10.1159/000026244
- By:
- Publication type:
- Article